Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxabact in Primary Hyperoxaluria
NCT00638703Phase 3Completed
- Sponsor
- OxThera AB
- Start
- Oct 2007
- Primary completion
- Sep 2008
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of oxalobacter formigenes in Primary hyperoxaluria (PH), sponsored by OxThera AB. Started Oct 2007; status: completed.
02
Drugs
oxalobacter formigenes
03
Conditions
Primary hyperoxaluria (PH)
Beyond the preview
Go deeper on NCT00638703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00638703.